# Delayed Microbiological Diagnosis and Fluoroquinolone-Associated Tendon Rupture in Pulmonary Nocardiosis Complicating Autoimmune Pulmonary Alveolar Proteinosis: A Case Report

**Authors:** Enrico Fulco

PMC · DOI: 10.7759/cureus.104445 · Cureus · 2026-02-28

## TL;DR

A rare case of pulmonary nocardiosis in a patient with autoimmune PAP highlights delayed diagnosis and a severe side effect from fluoroquinolone treatment.

## Contribution

This case report adds to the understanding of nocardiosis in autoimmune PAP and the risk of fluoroquinolone-induced tendon rupture.

## Key findings

- Delayed microbiological diagnosis of Nocardia wallacei in a patient with autoimmune PAP.
- Fluoroquinolone therapy led to a tendon rupture in the patient.
- Multidrug treatment and cotrimoxazole prophylaxis achieved clinical stability.

## Abstract

This report describes pulmonary nocardiosis in autoimmune pulmonary alveolar proteinosis (PAP), characterized by delayed microbiological diagnosis and a severe fluoroquinolone-associated adverse reaction. The autoimmune form, mediated by anti-granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies, predisposes patients to opportunistic infections due to impaired alveolar macrophage function. We describe a 48-year-old male smoker with a history of recurrent respiratory infections who presented with fever and hypoxemic respiratory failure. High-resolution CT demonstrated bilateral ground-glass opacities with superimposed interlobular septal thickening, consistent with a diffuse crazy-paving pattern predominantly involving the lower lobes, associated with focal consolidations in the left lower and right upper lobes. Despite initiation of broad-spectrum antimicrobial therapy, the patient exhibited clinical deterioration characterized by recurrence of fever, rising inflammatory markers (C-reactive protein (CRP) 298 mg/L), worsening hypoxemia with a decline in the PaO₂/FiO₂ ratio to 168, and radiological progression on repeat high-resolution computed tomography (HRCT), demonstrating increased areas of consolidation and expansion of ground-glass opacities. A milky-appearing bronchoalveolar lavage (BAL) initially yielded negative cultures; however, after 14 days of incubation, it revealed growth of Nocardia wallacei, identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). A diagnosis of autoimmune PAP was confirmed through the detection of anti-GM-CSF antibodies. The clinical course was complicated by relapse and a left-sided tendon rupture occurring after 10 days of fluoroquinolone therapy. The patient eventually achieved stability through a multidrug regimen followed by long-term secondary prophylaxis with cotrimoxazole for a total of 12 months. This case underscores the diagnostic challenge posed by slow-growing pathogens in patients with underlying rare lung diseases and highlights the necessity of maintaining a high index of suspicion for opportunistic infections when standard treatments fail.

## Linked entities

- **Proteins:** CSF2 (colony stimulating factor 2)
- **Chemicals:** cotrimoxazole (PubChem CID 358641)
- **Diseases:** autoimmune pulmonary alveolar proteinosis (MONDO:0012579), respiratory failure (MONDO:0021113)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}
- **Diseases:** respiratory infections (MESH:D012141), smoker (MESH:C000719328), lung diseases (MESH:D008171), hypoxemia (MESH:D000860), autoimmune (MESH:D001327), Tendon Rupture (MESH:D012421), opportunistic infections (MESH:D009894), inflammatory (MESH:D007249), Pulmonary Nocardiosis (MESH:D009617), hypoxemic respiratory failure (MESH:D012131), reaction (MESH:D006967), fever (MESH:D005334), Autoimmune Pulmonary Alveolar Proteinosis (MESH:C567049), PAP (MESH:D011649)
- **Chemicals:** Fluoroquinolone (MESH:D024841), cotrimoxazole (MESH:D015662)
- **Species:** Nocardia wallacei (species) [taxon 480035], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13035248/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13035248/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC13035248/full.md

---
Source: https://tomesphere.com/paper/PMC13035248